Advertisement
About AtriCure, Inc.
AtriCure, Inc. is a medical device company focused on developing,manufacturing and selling innovative cardiac surgical devices designed tocreate precise lesions, or scars, in cardiac and soft tissues. Medicaljournals have described the adoption by leading cardiothoracic surgeons of theAtriCure Isolator(R) bipolar ablation clamps as a treatment alternative duringopen-heart surgical procedures to create lesions in cardiac, or heart, tissueto block the abnormal electrical impulses that cause atrial fibrillation, orAF, a rapid, irregular quivering of the upper chambers of the heart.Additionally, leading cardiothoracic surgeons have described the AtriCureIsolator(R) bipolar ablation clamps as a promising treatment alternative forpatients who may be candidates for sole-therapy minimally invasive procedures.AF affects more than 2.5 million Americans and predisposes them to a five-foldincreased risk of stroke.
Advertisement
The FDA has cleared the AtriCure Isolator(R) bipolar ablation system forthe ablation, or destruction, of cardiac and soft tissues in cardiac andgeneral surgical procedures but has not yet cleared or approved the system forthe treatment of AF. The FDA has cleared the AtriCure multifunctional bipolarpen for the ablation of cardiac tissue and for temporary pacing, sensing,stimulating and recording during the evaluation of cardiac arrhythmias, butthe multifunctional bipolar pen has not been approved for the treatment of AF.Contact: AtriCure, Inc. Julie A. Piton Vice President and Chief Financial Officer (513) 755-4561 [email protected]
SOURCE AtriCure, Inc.
